Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole
- 1 September 2000
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 2 (3) , 140-144
- https://doi.org/10.1034/j.1399-3062.2000.020307.x
Abstract
This report describes the diagnosis and management of a 16‐year‐old boy who developed neurological signs and symptoms suggestive of cerebral aspergillosis following a haploidentical bone marrow trans...Keywords
This publication has 7 references indexed in Scilit:
- Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipientsBone Marrow Transplantation, 1998
- A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida kruseiAntimicrobial Agents and Chemotherapy, 1997
- Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patientsJournal of Infection, 1997
- Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion columnJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996
- Localization of Aspergillosis to the Central Nervous System Among Patients with Acute Leukemia: Report of 14 CasesClinical Infectious Diseases, 1996
- Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosisThe Pediatric Infectious Disease Journal, 1996